 | Up a level |
Number of items: 1.
Bowman, Simon J, Fox, Robert, Doerner, Thomas, Mariette, Xavier, Papas, Athena, Grader-Beck, Thomas, Fisher, Benjamin A, Barcelos, Filipe, De Vita, Salvatore, Schulze-Koops, Hendrik et al (show 6 more authors)
(2022)
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjogren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.
LANCET, 399 (10320).
pp. 161-171.
